Suppr超能文献

Ⅰ期和Ⅱ期结肠癌淋巴结微转移的临床意义。

Clinical significance of lymph node micrometastasis in stage I and II colon cancer.

机构信息

Department of Surgery, Kyung Hee University College of Medicine, Seoul, Korea.

出版信息

Cancer Res Treat. 2008 Jun;40(2):75-80. doi: 10.4143/crt.2008.40.2.75. Epub 2008 Jun 30.

Abstract

PURPOSE

A 25% rate of recurrence after performing complete resection in node-negative colon cancer patients suggests that their nodal staging is frequently suboptimal. Moreover, the value of occult cancer cells in tumor-free lymph nodes still remains uncertain. The authors evaluated the prognostic significance of the pathologic parameters, including the lymph node occult disease (micrometastases) detected by immunohistochemistry, in patients with node-negative colon cancer.

MATERIALS AND METHODS

The study included 160 patients with curatively resected stage I or II colon cancer and they were without rectal cancer. 2852 lymph nodes were re-examined by re-do hematoxylin and eosin (H-E) staining and immunohistochemical staining. The detection rates were compared with the clinicopathologic characteristics and with the cancer-specific survival.

RESULTS

Occult metastases were detected in 8 patients (5%). However, no clinicopathologic parameter was found to be correlated with the presence of micrometastasis. Twenty patients developed recurrence at a median follow-up of 45.7 months: 14 died of colon cancer and 9 died from noncancer-related causes. Univariate analysis showed that lymphatic invasion and the number of retrieved lymph nodes significantly influenced survival, and multivariate analysis revealed that the stage, the number of retrieved lymph nodes and lymphatic invasion were independently related to the prognosis.

CONCLUSIONS

Inadequate lymph node retrieval and lymphatic invasion were found to be associated with a poorer outcome for node-negative colon cancer patients. The presence of immunostained tumors cells in pN0 lymph nodes was found to have no significant effect on survival, but these tumor were identified by re-do H-E staining. Maximal attention should be paid to the total number of lymph nodes that are retrieved during surgery for colon cancer patients.

摘要

目的

在淋巴结阴性的结肠癌患者中,完全切除后复发率为 25%,这表明其淋巴结分期常常不够理想。此外,肿瘤无转移的淋巴结中隐匿性癌细胞的价值仍不确定。作者评估了病理参数(包括免疫组化检测到的淋巴结隐匿性疾病(微转移))在淋巴结阴性结肠癌患者中的预后意义。

材料与方法

该研究纳入了 160 例经根治性切除的 I 期或 II 期结肠癌患者,且无直肠癌患者。对 2852 枚淋巴结进行重新苏木精-伊红(H-E)染色和免疫组化染色复查。比较检测结果与临床病理特征及癌症特异性生存的关系。

结果

8 例(5%)患者检测到隐匿性转移。然而,未发现任何临床病理参数与微转移的存在相关。20 例患者在中位随访 45.7 个月时出现复发:14 例死于结肠癌,9 例死于非癌症相关原因。单因素分析显示,淋巴管浸润和检出的淋巴结数量显著影响生存,多因素分析显示,分期、检出的淋巴结数量和淋巴管浸润与预后独立相关。

结论

检出的淋巴结取样不足和淋巴管浸润与淋巴结阴性结肠癌患者的不良预后相关。在 pN0 淋巴结中存在免疫染色肿瘤细胞与生存无显著相关性,但这些肿瘤可通过重新进行 H-E 染色发现。在为结肠癌患者进行手术时,应高度重视检出的淋巴结总数。

相似文献

1
Clinical significance of lymph node micrometastasis in stage I and II colon cancer.
Cancer Res Treat. 2008 Jun;40(2):75-80. doi: 10.4143/crt.2008.40.2.75. Epub 2008 Jun 30.
4
Prognostic Value of Mesorectal Lymph Node Micrometastases in ypN0 Rectal Cancer After Chemoradiation.
J Surg Res. 2022 Aug;276:314-322. doi: 10.1016/j.jss.2022.02.040. Epub 2022 Apr 12.
5
Is lymph-node micrometastasis in gallbladder cancer a significant prognostic factor?
Hepatogastroenterology. 2012 Jan-Feb;59(113):31-5. doi: 10.5754/hge10010.
7
Lymph node micrometastases do not predict relapse in stage II colon cancer.
Ann Surg Oncol. 2000 Sep;7(8):601-8. doi: 10.1007/BF02725340.
8
10
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Ann Surg. 2007 Oct;246(4):568-75; discussion 575-7. doi: 10.1097/SLA.0b013e318155a9c7.

引用本文的文献

1
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection.
World J Gastroenterol. 2022 Aug 14;28(30):4019-4043. doi: 10.3748/wjg.v28.i30.4019.
3
Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies.
Mol Clin Oncol. 2013 Jul;1(4):582-592. doi: 10.3892/mco.2013.116. Epub 2013 May 9.
4
Early stage colon cancer.
World J Gastroenterol. 2013 Dec 14;19(46):8468-73. doi: 10.3748/wjg.v19.i46.8468.
5
Lymph node micrometastasis in gastrointestinal tract cancer--a clinical aspect.
Int J Clin Oncol. 2013 Oct;18(5):752-61. doi: 10.1007/s10147-013-0577-y. Epub 2013 Jun 18.
6
Prognostic significance of histologically detected lymph node micrometastases of sizes between 0.2 and 2 mm in colorectal cancer.
Int J Colorectal Dis. 2013 Jul;28(7):977-83. doi: 10.1007/s00384-012-1636-y. Epub 2013 Jan 12.
8
Impact on Prognosis of Lymph Node Micrometastasis and Isolated Tumor Cells in Stage II Colorectal Cancer.
J Korean Soc Coloproctol. 2011 Apr;27(2):71-7. doi: 10.3393/jksc.2011.27.2.71. Epub 2011 Apr 30.
9
Cytokeratin staining for complete remission in rectal cancer after chemoradiation.
Int J Colorectal Dis. 2010 Jul;25(7):805-9. doi: 10.1007/s00384-010-0944-3. Epub 2010 Apr 24.

本文引用的文献

1
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Ann Surg. 2007 Oct;246(4):568-75; discussion 575-7. doi: 10.1097/SLA.0b013e318155a9c7.
2
Cancer statistics, 2007.
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
3
4
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
J Clin Oncol. 2004 Aug 15;22(16):3408-19. doi: 10.1200/JCO.2004.05.063. Epub 2004 Jun 15.
5
Detection of lymphatic micrometastases in patients with stages I and II colorectal cancer: impact on five-year survival.
Dis Colon Rectum. 2004 Jul;47(7):1151-7. doi: 10.1007/s10350-004-0560-9. Epub 2004 May 28.
8
Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.
Dis Colon Rectum. 2002 Jun;45(6):750-5; discussion755-6. doi: 10.1007/s10350-004-6291-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验